diff --git a/wiki/pages/engineering.html b/wiki/pages/engineering.html
index 3d6ab36977592f41d17921704807168452e5531c..bd277791c8a8d7a4abf985ce849088ce31eda8de 100644
--- a/wiki/pages/engineering.html
+++ b/wiki/pages/engineering.html
@@ -284,60 +284,42 @@
     <div class="grid-content right-short">
         <h1>Learn</h1>
         <p>
-            Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam venenatis ex nibh, quis
-            imperdiet
-            lectus hendrerit vitae. Nulla non ex suscipit, fringilla enim gravida, mollis ante. Nullam
-            vel
-            vestibulum orci. Curabitur id ex ligula. Suspendisse maximus arcu sagittis, ultricies sapien
-            at,
-            posuere sem. Cras vel dolor lobortis, vehicula metus nec, ullamcorper diam. Sed pretium nibh
-            lectus,
-            id euismod urna consectetur non. Nulla facilisi. Praesent congue magna ac neque lobortis,
-            vel
-            sagittis neque euismod. Donec venenatis augue quis lorem fermentum, id dapibus nunc
-            pharetra.
-            Praesent aliquam gravida lacus, sit amet rhoncus nunc dignissim quis.<br/><br/>
-
-            Quisque rhoncus libero quis odio ornare maximus. Vivamus quis condimentum massa. In luctus
-            hendrerit
-            dolor, quis blandit nisi porta accumsan. Nullam neque sapien, molestie non ex convallis,
-            ornare
-            consectetur ante. Integer a, <strong>gravida enim sed</strong>, molestie sem. Nam tincidunt
-            sapien
-            et
-            justo cursus, ut placerat sem sagittis. Cras maximus purus augue, ut cursus nunc
-            pellentesque
-            ut.
-            Fusce commodo libero et egestas rutrum. Cras ac justo lorem. Maecenas tempus ut leo sit amet
-            rutrum.<br/><br/>
-
-            Morbi blandit cursus diam id ultrices. Vestibulum a vulputate justo. Quisque volutpat
-            finibus
-            efficitur. Ut ultricies nibh non arcu suscipit dapibus. Phasellus interdum bibendum nibh sed
-            tincidunt. Pellentesque in felis metus. Phasellus euismod consequat dignissim. Proin in
-            efficitur
-            tortor. Quisque sagittis facilisis tortor nec commodo. Integer condimentum sagittis luctus.
-
-            Phasellus congue rhoncus eros, euismod efficitur neque. Etiam sagittis vitae ligula non
-            iaculis.
-            In
-            volutpat sollicitudin risus nec venenatis. Donec elementum, sem eu ornare bibendum, enim
-            tortor
-            cursus mauris, sit amet dignissim risus ante vel justo. Sed fermentum erat id nibh interdum
-            sollicitudin. Vestibulum tempor metus ac libero maximus semper. Donec sed ligula neque.
-            Morbi
-            sagittis orci odio, eget blandit urna molestie hendrerit. Fusce orci tellus, iaculis at
-            pretium
-            et,
-            convallis in tortor. Curabitur finibus orci tortor, eget euismod lectus imperdiet quis.</p>
+            Through our tests, we were able to learn many things about our aptamer probe. For example, we learned that
+            the aptamer probes had much weaker fluorescence values than we had imagined. With a 100µL solution of 500µM
+            aptamer solution and 500µM biomarker solution, the maximum Relative Fluorescence Unit (RFU) was 846. While
+            this is a measurable value, we realized that there is much more research needed to improve this system and
+            increase the RFU value in some way. This would be able to prevent false positives during screenings, and we
+            would recommend other teams to explore this topic of amplification.<br><br>
+            Furthermore, we were able to verify the specificity and durability of aptamers. Although we did know through
+            literature that aptamers were better in terms of specificity and durability compared to antibodies, we were
+            able to verify this through our specificity test and shelf life test. Our experiments build off of prior
+            experiments with aptamers, and is another example of the versatility of aptamers probes.<br><br>
+            We also learned that the FRET mechanism works very well. In our experiments, when we had only a solution of
+            S2.2 aptamer probes without Mucin 1 biomarkers, the aptamer probes virtually did not fluoresce, since the
+            RFU values were similar to that of pure buffer solution. This exemplifies the high accuracy of the aptamer
+            probe mechanism utilizing the FRET mechanism to make the aptamer probes only fluoresce in the presence of
+            the desired target.
+        </p>
     </div>
     <div class="grid-gap"></div>
     <div class="grid-gap"></div>
     <div class="grid-content left-short">
         <h1>Design</h1>
         <p>
-
-
+            We explored various previous literature conducted on breast cancer patients, as well as literature on the
+            detection of breast cancer through the ELISA method detecting levels of Mucin 1 biomarker. As shown in the
+            box and whisker chart below, literature showed that the error bars of the standard mean error overlapped
+            between breast cancer patients and healthy patients.
+        <div style="display: flex; flex-direction: column; align-items: center; width: 100%; margin: 14px 0">
+            <img width="50%" src="https://static.igem.wiki/teams/4334/wiki/engineeringchart.png">
+            <div class="smaller">(Werfalli, et al.)</div>
+        </div>
+        Thus, we determined that our method may not provide the most accurate assessment of who requires further
+        screening due to risk of false positives—and alarming potential patients is a situation we’d like to avoid. For
+        this reason, we propose to implement our screening method to detect diseases where any presence of biomarkers is
+        an indication for the necessity of treatment (including hepatitis B virus). When it comes to breast cancer
+        applications, we propose to apply this method in the future where technology for the identification of Mucin 1
+        biomarker concentrations in patients with breast cancer have improved.
         </p>
     </div>
     <div class="grid-gap"></div>